Resources Contact Us Home
Modified factor VIII

Image Number 6 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Systems and methods for optimizing capital structure of a financial institution
Pyrazole kinase modulators and methods of use
Providing a multi-tenant knowledge network
System and method of interfacing co-processors and input/output devices via a main memory system
Badge or pin
Magnetic disk and manufacturing method thereof
Projection screen and projection system having the same
  Randomly Featured Patents
Container apparatus of a vehicle
Poultry transport compartment with inwardly opening doors
Flange coupling
Twin jet drive for watercraft
Container for holding biologic fluid for analysis
Lace system for footwear
Relay substrate and substrate assembly
Semiconductor devices with active semiconductor height variation
Anti spinning device, a vehicle comprising the device and a method for reducing slip during advancing of a vehicle
Melanoma differentiation associated gene-5 and promoter and uses thereof